Assay Development and Screening of a Serine/Threonine Kinase in an On-Chip Mode Using Caliper Nanofluidics Technology
暂无分享,去创建一个
[1] Christophe Cleva,et al. Chemical substructures in drug discovery. , 2003, Drug discovery today.
[2] Robert Schweitzer,et al. Comparison of Assay Technologies for a Tyrosine Kinase Assay Generates Different Results in High Throughput Screening , 2002, Journal of biomolecular screening.
[3] P. Cohen. Protein kinases — the major drug targets of the twenty-first century? , 2002, Nature reviews. Drug discovery.
[4] G. Zaman,et al. High-throughput screening with immobilized metal ion affinity-based fluorescence polarization detection, a homogeneous assay for protein kinases. , 2003, Assay and drug development technologies.
[5] Jude Dunne,et al. Comparison of on-chip and off-chip microfluidic kinase assay formats. , 2004, Assay and drug development technologies.
[6] D. Auld,et al. Evaluation of compound interference in immobilized metal ion affinity-based fluorescence polarization detection with a four million member compound collection. , 2003, Assay and drug development technologies.
[7] R. Eglen,et al. A High-Throughput, Nonisotopic, Competitive Binding Assay for Kinases Using Nonselective Inhibitor Probes (ED-NSIP™) , 2002, Journal of biomolecular screening.
[8] Ying Li,et al. Homogeneous assays for adenosine 5'-monophosphate-activated protein kinase. , 2003, Analytical biochemistry.
[9] A. Woods,et al. Homogeneous proximity tyrosine kinase assays: scintillation proximity assay versus homogeneous time-resolved fluorescence. , 1999, Analytical biochemistry.
[10] A. Clerk,et al. Kinases as therapeutic targets for heart failure , 2003, Nature Reviews Drug Discovery.
[11] A. Kannt,et al. Two Simple and Generic Antibody-Independent Kinase Assays: Comparison of a Bioluminescent and a Microfluidic Assay Format , 2004, Journal of biomolecular screening.
[12] Doriano Fabbro,et al. Targeting protein kinases in cancer therapy. , 2002, Current opinion in drug discovery & development.
[13] D. Fabbro,et al. Imatinib: a selective tyrosine kinase inhibitor. , 2002, European journal of cancer.
[14] Frederick G. Harrison. Selecting Process Equipment Vendors , 1985, Bio/Technology.
[15] T. de Boer,et al. Fluorescence assays for high-throughput screening of protein kinases. , 2003, Combinatorial chemistry & high throughput screening.
[16] Gregory J. Parker,et al. Development of High Throughput Screening Assays Using Fluorescence Polarization: Nuclear Receptor-Ligand-Binding and Kinase/Phosphatase Assays , 2000, Journal of biomolecular screening.
[17] H. Yazawa,et al. Development of a Homogeneous Time-Resolved Fluorescence Assay for High Throughput Screening to Identify Lck Inhibitors: Comparison with Scintillation Proximity Assay and Streptavidin-Coated Plate Assay , 2000, Journal of biomolecular screening.
[18] Frank H Büttner,et al. Miniaturization and Validation of a High-Throughput Serine Kinase Assay Using the Alpha Screen Platform , 2004, Journal of biomolecular screening.
[19] Thomas D. Y. Chung,et al. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.
[20] A. Pope. Introduction LANCE™ vs. HTRF® Technologies (or Vice Versa) , 1999 .
[21] M. Vieth,et al. Kinomics: characterizing the therapeutically validated kinase space. , 2005, Drug discovery today.
[22] J. Sportsman,et al. A Homogeneous Fluorescence Polarization Assay Adaptable for a Range of Protein Serine/Threonine and Tyrosine Kinases , 2003, Journal of biomolecular screening.
[23] L. Wodicka,et al. A small molecule–kinase interaction map for clinical kinase inhibitors , 2005, Nature Biotechnology.